Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

3140.13 (Glytoucan)

Id:a5deb05a-b7be-5867-9ad3-b004ac4248c2

Glytoucan:G41759WX

Results found

Linked to

	Label	Description
	3140.13 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000020 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	3140.13 has glycosequence GLYGEN.GLYCOSEQUENCE:G60042VS-GLYCOSEQ00054008 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	3140.13 has glycosequence GLYGEN.GLYCOSEQUENCE:G57727DJ-GLYCOSEQ00155083 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	3140.13 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000022 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	3140.13 has glycosequence GLYGEN.GLYCOSEQUENCE:G60042VS-GLYCOSEQ00054007 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	3140.13 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000055 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	3140.13 has glycosequence GLYGEN.GLYCOSEQUENCE:G42966HS-GLYCOSEQ00099314 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	3140.13 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000056 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	3140.13 has canonical residue n-glycan core b-d-glcpnac b Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	3140.13 has glycosequence GLYGEN.GLYCOSEQUENCE:G57727DJ-GLYCOSEQ00155084 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

3140.13 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000020 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

3140.13 has glycosequence GLYGEN.GLYCOSEQUENCE:G60042VS-GLYCOSEQ00054008 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

3140.13 has glycosequence GLYGEN.GLYCOSEQUENCE:G57727DJ-GLYCOSEQ00155083 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

3140.13 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000022 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

3140.13 has glycosequence GLYGEN.GLYCOSEQUENCE:G60042VS-GLYCOSEQ00054007 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

3140.13 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000055 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

3140.13 has glycosequence GLYGEN.GLYCOSEQUENCE:G42966HS-GLYCOSEQ00099314 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

3140.13 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000056 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

3140.13 has canonical residue n-glycan core b-d-glcpnac b

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

3140.13 has glycosequence GLYGEN.GLYCOSEQUENCE:G57727DJ-GLYCOSEQ00155084 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.